🇺🇸 Fecal Microbiota Transplantation in United States
9 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 9
Most-reported reactions
- Sepsis — 2 reports (22.22%)
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy — 1 report (11.11%)
- Drug Ineffective — 1 report (11.11%)
- Gastroenteritis Escherichia Coli — 1 report (11.11%)
- Guillain-Barre Syndrome — 1 report (11.11%)
- Malaise — 1 report (11.11%)
- Paralysis — 1 report (11.11%)
- Probiotic Therapy — 1 report (11.11%)
Other Gastroenterology / Infectious Disease approved in United States
Frequently asked questions
Is Fecal Microbiota Transplantation approved in United States?
Fecal Microbiota Transplantation does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Fecal Microbiota Transplantation in United States?
University of California, Los Angeles is the originator. The local marketing authorisation holder may differ — check the official source linked above.